Niizeki T, Mawatari S, Shibata M, Sasaki R, et al. Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria. J Gastroenterol Hepatol 2025 May 31. doi: 10.1111/jgh.17024.
PMID: 40448543